Retroscreen Virology Group plc announced strategic changes to its Board of Directors (Board) as part of the company's ambitious growth strategy. Professor John Oxford, one of the founders of the company and Duncan Peyton, who represented a pre-IPO investor the Northern Entrepreneurs Fund, are both retiring as Directors by rotation at the company's AGM on 21 May 2014 and not seeking re-appointment. In addition, Dr. Trevor Nicholls, an experienced company Director with a strong track record in the bioinformatics field, is being proposed at the company's AGM to join the Board as a Non-Executive Director.

Trevor is a company director having over 30 years' experience of building international businesses in the life science industry, with a strong focus on genomics and proteomics. In particular, he was previously Chairman of Oxford Nanopore Technologies Limited, is currently Chairman of Avacta Group plc and was the Chairman of Activiomics Limited prior to its recent acquisition by Retroscreen. Trevor is also Chief Executive Officer of CABI.